Atelosteogenesis Type 1 Overview
Learn About Atelosteogenesis Type 1
Atelosteogenesis type 1 is a disorder that affects the development of bones throughout the body. Affected individuals are born with inward- and upward-turning feet (clubfeet) and dislocations of the hips, knees, and elbows. Bones in the spine, rib cage, pelvis, and limbs may be underdeveloped or in some cases absent. As a result of the limb bone abnormalities, individuals with this condition have very short arms and legs. Characteristic facial features include a prominent forehead, wide-set eyes (hypertelorism), an upturned nose with a grooved tip, and a very small lower jaw and chin (micrognathia). Affected individuals may also have an opening in the roof of the mouth (a cleft palate). Males with this condition can have undescended testes.
Mutations in the FLNB gene cause atelosteogenesis type 1. The FLNB gene provides instructions for making a protein called filamin B. This protein helps build the network of protein filaments (cytoskeleton) that gives structure to cells and allows them to change shape and move. Filamin B attaches (binds) to another protein called actin and helps the actin to form the branching network of filaments that makes up the cytoskeleton. Filamin B also links actin to many other proteins to perform various functions within the cell, including the cell signaling that helps determine how the cytoskeleton will change as tissues grow and take shape during development.
Atelosteogenesis type 1 is a rare disorder; its exact prevalence is unknown. Only a few dozen affected individuals have been identified.
This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. Almost all cases result from new mutations in the gene and occur in people with no history of the disorder in their family.
Group Health Plan Inc
Katherine Munck is a Pediatrics specialist and an Internal Medicine provider in Saint Paul, Minnesota. Dr. Munck and is rated as an Experienced provider by MediFind in the treatment of Atelosteogenesis Type 1. Her top areas of expertise are Down Syndrome, Dysferlinopathy, Van Maldergem Syndrome, and Caudal Duplication. Dr. Munck is currently accepting new patients.
Healtheast Medical Research Institute
Shehla Kamal is an Internal Medicine provider in Woodbury, Minnesota. Dr. Kamal and is rated as an Experienced provider by MediFind in the treatment of Atelosteogenesis Type 1. Her top areas of expertise are Hyperlipidemia Type 3, Opioid Use Disorder, Cirrhosis, and High Cholesterol. Dr. Kamal is currently accepting new patients.
University Of Minnesota Health Clinics And Surgery Center Inc
David Walk is a Neurologist in Minneapolis, Minnesota. Dr. Walk and is rated as an Experienced provider by MediFind in the treatment of Atelosteogenesis Type 1. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Charcot-Marie-Tooth Disease, Spinal Muscular Atrophy Type 3, and Primary Lateral Sclerosis. Dr. Walk is currently accepting new patients.
Summary: The aim of the current study is to evaluate the safety and efficacy of low dose treosulfan based conditioning regimen in HSCT with post-transplant cyclophosphamide in Nijmegen breakage syndrome
Published Date: September 01, 2011
Published By: National Institutes of Health